̽»¨Ö±²¥

Professor Duncan Richards has today been announced as the new Head of the Department of Medicine at the ̽»¨Ö±²¥ of Cambridge.

Cambridge scientists have developed a urine test for early detection of lung cancer. ̽»¨Ö±²¥test, the first of its kind, detects ‘zombie’ cells that could indicate the first signs of the disease.

A pivotal clinical trial of a 'pill-on-a-thread' test, which will decide if it becomes a new screening programme for oesophageal cancer, has welcomed its first participants.

̽»¨Ö±²¥Human Cell Atlas is an ambitious project to map every cell in the human body. Its co-lead, Professor Sarah Teichmann, explains how the initiative is already changing our understanding of our bodies.

Researchers have developed a mindfulness therapy tailored specifically to appeal to teenagers to help them cope with increasing levels of depression and mental health problems.

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in Alzheimer’s disease.

A type of therapy that involves applying a magnetic field to both sides of the brain has been shown to be effective at rapidly treating depression in patients for whom standard treatments have been ineffective.

Professor David Rowitch, Head of the Department of Paediatrics at the ̽»¨Ö±²¥ of Cambridge, has been elected to the prestigious National Academy of Medicine in the USA.

̽»¨Ö±²¥ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.

10 Cambridge spinouts on putting their research into practice to improve outcomes for cancer patients - and why Cambridge is a great place to do this.